NGR-modified micelles enhance their interaction with CD13-overexpressing tumor and endothelial cells

Journal of Controlled Release

Volumn 139, Issue 1, 2009, Pages 56-62

  Wang, Xun ^a   Wang, Yiguang ^a   Chen, Xiaomei ^a   Wang, Jiancheng ^a   Zhang, Xuan ^a   Zhang, Qiang ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

CD13; CD13 overexpressing tumor; Docetaxel; NGR; Polymeric micelles

Indexed keywords

CD13; CD13-OVEREXPRESSING TUMOR; DOCETAXEL; NGR; POLYMERIC MICELLES;

AMINES; BLOOD VESSEL PROSTHESES; CELL MEMBRANES; ENCAPSULATION; IMAGE ANALYSIS; MICELLES; PERMANENT MAGNETS; POLYETHYLENE GLYCOLS; POLYMERS; SELF ASSEMBLY; TUMORS;

ENDOTHELIAL CELLS;

ARGININE; ASPARAGINE; DOCETAXEL; GLYCINE; MACROGOL; MICROSOMAL AMINOPEPTIDASE; POLYLACTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BODY WEIGHT; CANCER CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ENCAPSULATION; ENDOCYTOSIS; ENDOTHELIUM CELL; FIBROSARCOMA; HUMAN; HUMAN CELL; HYDROPHOBICITY; IMAGE ANALYSIS; IN VITRO STUDY; IN VIVO STUDY; MALE; MICELLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SPECTROFLUOROMETRY; TUMOR CELL; TUMOR XENOGRAFT; UMBILICAL VEIN;

ANIMALS; ANTIGENS, CD13; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CHEMISTRY, PHARMACEUTICAL; DRUG COMPOUNDING; DRUG STABILITY; ENDOTHELIAL CELLS; HUMANS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICELLES; MICROSCOPY, CONFOCAL; OLIGOPEPTIDES; PARTICLE SIZE; TAXOIDS; TEMPERATURE; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 68949204885     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2009.05.030     Document Type: Article

References (28)

1. Cortes J.E., and Pazdur R. Docetaxel. J. Clin. Oncol. 13 10 (1995) 2643-2655
2. Nasongkla N., Shuai X., Ai H., Weinberg B.D., Pink J., Boothman D.A., and Gao J. cRGD-functionalized polymer micelles for targeted doxorubicin delivery. Angew. Chem., Int. Ed. 43 46 (2004) 6323-6327
3. Nishiyama N., Okazaki S., Cabral H., Miyamoto M., Kato Y., Sugiyama Y., Nishio K., Matsumura Y., and Kataoka K. Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice. Cancer Res. 63 24 (2003) 8977-8983
4. Gao Z.G., Fain H.D., and Rapoport N. Controlled and targeted tumor chemotherapy by micellar-encapsulated drug and ultrasound. J. Control. Release 102 1 (2005) 203-222
5. Savic R., Luo L., Eisenberg A., and Maysinger D. Micellar nanocontainers distribute to defined cytoplasmic organelles. Science 300 5619 (2003) 615-618
6. Zhang X., Jackson J.K., and Burt H.M. Development of amphiphilic diblock copolymers as micellar carriers of taxol. Int. J. Pharm. 132 (1996) 195-206
7. Yasugi K., Nagasaki Y., Kato M., and Kataoka K. Preparation and characterization of polymer micelles from poly(ethylene glycol)-poly(d,l-lactide) block copolymers as potential drug carrier. J. Control. Release 62 1-2 (1999) 89-100
8. Cabral H., Nishiyama N., and Kataoka K. Optimization of (1,2-diamino-cyclohexane) platinum(II)-loaded polymeric micelles directed to improved tumor targeting and enhanced antitumor activity. J. Control. Release 121 3 (2007) 146-155
9. Yang Z.L., Li X.R., Yang K.W., and Liu Y. Amphotericin B-loaded poly(ethylene glycol)-poly(lactide) micelles: preparation, freeze-drying, and in vitro release. J. Biomed. Mater. Res. 85 2 (2008) 539-546
10. Kim D.W., Kim S.Y., Kim H.K., Kim S.W., Shin S.W., Kim J.S., Park K., Lee M.Y., and Heo D.S. Multicenter phase II trial of Genexol-PM, a novel Cremophor-free, polymeric micelle formulation of paclitaxel, with cisplatin in patients with advanced non-small-cell lung cancer. Ann. Oncol. 18 12 (2007) 2009-2014
11. Yamamoto Y., Nagasaki Y., Kato Y., Sugiyama Y., and Kataoka K. Long-circulating poly(ethylene glycol)-poly(d,l-lactide) block copolymer micelles with modulated surface charge. J. Control. Release 77 1-2 (2001) 27-38
12. Arap W., Pasqualini R., and Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 279 5349 (1998) 377-380
13. Pasqualini R., Koivunen E., Kain R., Lahdenranta J., Sakamoto M., Stryhn A., Ashmun R.A., Shapiro L.H., Arap W., and Ruoslahti E. Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res. 60 3 (2000) 722-727
14. Saiki I., Fujii H., Yoneda J., Abe F., Nakajima M., Tsuruo T., and Azuma I. Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int. J. Cancer 54 1 (1993) 137-143
15. Curnis F., Arrigoni G., Sacchi A., Fischetti L., Arap W., Pasqualini R., and Corti A. Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells. Cancer Res. 62 3 (2002) 867-874
16. Colombo G., Curnis F., De Mori G.M., Gasparri A., Longoni C., Sacchi A., Longhi R., and Corti A. Structure-activity relationships of linear and cyclic peptides containing the NGR tumor-homing motif. J. Biol. Chem. 277 49 (2002) 47,891-47,897
17. Ellerby H.M., Arap W., Ellerby L.M., Kain R., Andrusiak R., Rio G.D., Krajewski S., Lombardo C.R., Rao R., Ruoslahti E., Bredesen D.E., and Pasqualini R. Anti-cancer activity of targeted pro-apoptotic peptides. Nat Med 5 9 (1999) 1032-1038
18. Pastorino F., Brignole C., Marimpietri D., Cilli M., Gambini C., Ribatti D., Longhi R., Allen T.M., Corti A., and Ponzoni M. Vascular damage and anti-angiogenic effects of tumor vessel-targeted liposomal chemotherapy. Cancer Res 63 21 (2003) 7400-7409
19. Garde S.V., Forte A.J., Ge M., Lepekhin E.A., Panchal C.J., Rabbani S.A., and Wu J.J. Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects. Anti-cancer Drugs 18 10 (2007) 1189-1200
20. van Hensbergen Y., Broxterman H.J., Elderkamp Y.W., Lankelma J., Beers J.C., Heijn M., Boven E., Hoekman K., and Pinedo H.M. A doxorubicin-CNGRC-peptide conjugate with prodrug properties. Biochem. Pharmacol. 63 5 (2002) 897-908
21. Yokoyama Y., and Ramakrishnan S. Addition of an aminopeptidase N-binding sequence to human endostatin improves inhibition of ovarian carcinoma growth. Cancer 104 2 (2005) 321-331
22. Xiong X.B., Mahmud A., Uludag H., and Lavasanifar A. Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-b-poly(epsilon-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells. Biomacromolecules 8 3 (2007) 874-884
23. Vichai V., and Kirtikara K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat. Protoc. 1 3 (2006) 1112-1116
24. Burt H.M., Zhang X., Toleikis P., Embree L., and Hunter W.L. Development of copolymers of poly(d, l-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel. Colloids Surf. B 16 1-4 (1999) 161-171
25. Battafarano D.F., Zimmerman G.C., Older S.A., Keeling J.H., and Burris H.A. Docetaxel (Taxotere) associated scleroderma-like changes of the lower extremities. A report of three cases. Cancer 76 1 (1995) 110-115
26. ten Tije A.J., Verweij J., Loos W.J., and Sparreboom A. Pharmacological effects of formulation vehicles: implications for cancer chemotherapy. Clin. Pharmacokinet. 42 7 (2003) 665-685
27. Fournier E., Dufresne M.H., Smith D.C., Ranger M., and Leroux J.C. A novel one-step drug-loading procedure for water-soluble amphiphilic nanocarriers. Pharm. Res. 21 6 (2004) 962-968
28. Elsabahy M., Perron M.E., Bertrand N., Yu G.E., and Leroux J.C. Solubilization of docetaxel in poly(ethylene oxide)-block-poly(butylene/styrene oxide) micelles. Biomacromolecules 8 7 (2007) 2250-2257